biote Statistics
Total Valuation
biote has a market cap or net worth of $430.05 million. The enterprise value is $455.92 million.
| Market Cap | 430.05M |
| Enterprise Value | 455.92M |
Important Dates
The last earnings date was Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
biote has 74.53 million shares outstanding. The number of shares has increased by 219.00% in one year.
| Shares Outstanding | 74.53M |
| Shares Change (YoY) | +219.00% |
| Shares Change (QoQ) | -17.18% |
| Owned by Insiders (%) | 24.86% |
| Owned by Institutions (%) | 44.97% |
| Float | 16.73M |
Valuation Ratios
The trailing PE ratio is 44.38 and the forward PE ratio is 17.50.
| PE Ratio | 44.38 |
| Forward PE | 17.50 |
| PS Ratio | 2.32 |
| Forward PS | 2.08 |
| PB Ratio | n/a |
| P/FCF Ratio | 17.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.76, with an EV/FCF ratio of 18.86.
| EV / Earnings | 137.49 |
| EV / Sales | 2.46 |
| EV / EBITDA | 28.76 |
| EV / EBIT | 36.88 |
| EV / FCF | 18.86 |
Financial Position
The company has a current ratio of 5.51
| Current Ratio | 5.51 |
| Quick Ratio | 4.31 |
| Debt / Equity | n/a |
| Debt / EBITDA | 7.25 |
| Debt / FCF | 4.75 |
| Interest Coverage | 1.94 |
Financial Efficiency
Return on equity (ROE) is -8.00% and return on invested capital (ROIC) is 18.54%.
| Return on Equity (ROE) | -8.00% |
| Return on Assets (ROA) | 2.40% |
| Return on Capital (ROIC) | 18.54% |
| Revenue Per Employee | $955,464 |
| Profits Per Employee | $17,093 |
| Employee Count | 194 |
| Asset Turnover | 1.32 |
| Inventory Turnover | 4.06 |
Taxes
In the past 12 months, biote has paid $2.68 million in taxes.
| Income Tax | 2.68M |
| Effective Tax Rate | 44.71% |
Stock Price Statistics
The stock price has decreased by -16.38% in the last 52 weeks. The beta is 0.87, so biote's price volatility has been lower than the market average.
| Beta (1Y) | 0.87 |
| 52-Week Price Change | -16.38% |
| 50-Day Moving Average | 5.86 |
| 200-Day Moving Average | 5.29 |
| Relative Strength Index (RSI) | 51.03 |
| Average Volume (30 Days) | 116,668 |
Short Selling Information
The latest short interest is 1.03 million, so 1.38% of the outstanding shares have been sold short.
| Short Interest | 1.03M |
| Short Previous Month | 878,177 |
| Short % of Shares Out | 1.38% |
| Short % of Float | 6.15% |
| Short Ratio (days to cover) | 7.44 |
Income Statement
In the last 12 months, biote had revenue of $185.36 million and earned $3.32 million in profits. Earnings per share was $0.13.
| Revenue | 185.36M |
| Gross Profit | 127.48M |
| Operating Income | 28.66M |
| Pretax Income | 6.00M |
| Net Income | 3.32M |
| EBITDA | 15.85M |
| EBIT | 12.36M |
| Earnings Per Share (EPS) | $0.13 |
Balance Sheet
The company has $89.00 million in cash and $114.87 million in debt, giving a net cash position of -$25.87 million or -$0.35 per share.
| Cash & Cash Equivalents | 89.00M |
| Total Debt | 114.87M |
| Net Cash | -25.87M |
| Net Cash Per Share | -$0.35 |
| Equity / Book Value | -29.40M |
| Book Value Per Share | -0.39 |
| Working Capital | 100.13M |
Cash Flow
In the last 12 months, operating cash flow was $26.88 million and capital expenditures -$2.71 million, giving a free cash flow of $24.17 million.
| Operating Cash Flow | 26.88M |
| Capital Expenditures | -2.71M |
| Free Cash Flow | 24.17M |
| FCF Per Share | $0.94 |
Margins
Gross margin is 68.78%, with operating and profit margins of 15.46% and 1.79%.
| Gross Margin | 68.78% |
| Operating Margin | 15.46% |
| Pretax Margin | 3.24% |
| Profit Margin | 1.79% |
| EBITDA Margin | 8.55% |
| EBIT Margin | 6.67% |
| FCF Margin | 13.04% |
Dividends & Yields
biote does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -219.00% |
| Shareholder Yield | -219.00% |
| Earnings Yield | 0.77% |
| FCF Yield | 5.62% |
Analyst Forecast
The average price target for biote is $8.11, which is 40.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.11 |
| Price Target Difference | 40.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 17.15% |
| EPS Growth Forecast (5Y) | 64.82% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
biote has an Altman Z-Score of 3.31 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.31 |
| Piotroski F-Score | 7 |